Table 2.
Demographic and clinical characteristics of culture-positive and culture-negative Brucellosis patients
| Characteristics | Culture-positive Brucellosis (n = 51) | Culture-negative Brucellosis (n = 184) | P value |
|---|---|---|---|
| Mean age (mean ± SD), years | 48.39 ± 19.96 | 51.68 ± 17.38 | 0.248 |
| Male | 28 (54.90%) | 103 (56.0%) | 0.891 |
| Fever | 45 (88.23%) | 173 (94.02%) | 0.269 |
| Joint pain | 32 (62.75%) | 130 (70.65%) | 0.280 |
| Hepatosplenomegaly | 25 (49.02%) | 99 (53.80%) | 0.545 |
| WBC (mean ± SD), ×109/L | 5.82 ± 0.90 | 5.62 ± 0.90 | 0.160 |
| CRP (M, IQR), mg/L | 23 (8.01,42.0) | 18 (3.85, 32) | 0.037 |
| PCT (M, IQR), ng/L | 0.234 (0.128, 0.32) | 0.26 (0.166,0.345) | 0.116 |
| Focal involvement | 24 (47.06%) | 78 (42.39%) | 0.552 |
| Osteoarticular involvement | 13 (25.49%) | 50 (27.17%) | 0.810 |
| Genitourinary involvement | 5 (9.8%) | 15 (8.15%) | 0.928 |
| Neurological involvement | 2 (3.92%) | 3 (1.63%) | 0.297 |
| Pulmonary involvement | 4 (7.84%) | 10 (5.43%) | 0.758 |